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Lymphocyte-specific reconstitution of ILARu was recently established by intercrossing 
lymphocyte-specific human IL-4Ra transgenic mice with mIL-4Ra-deficient mice. 
I~uman ILARu may bind to mouse yc resulting in a chimeric receptor specific for human 
I LA but not mouse I L-4. This provides us with an inducible I L-4 system. The aim of this 
study was to investigate the in vitro and in vivo characteristics of ollr novel hlLARu 
Tg/mIL-4Ru-l - mOllse model. The integrity of the lymphocyte-specific hIL-4R(x 
expression in h1L-4Ra -rglmILARcx-l - mice was demonstrated by FACS analysis. 
Lymphocytes responded to hILA but not mILA or mlL-13 in proliferation and T helper 
differentiation assays, demonstrating the species-specificity and inducibility of the 
chimeric receptor in vitro. Non-lymphocytes like macrophages were unresponsive to 
mlL-4 and mlL-13 as assayed by IfN-y/LPS-induced NO production and arginase 
activity. The in vivo characteristics of h1L-4Ru Tg/mIL-4Ra-l - mice were studied using 2 
murine disease models: 1) the L mujor model and 2) the N. brasiliensis model. In 
contrast to mIL-4Ra- l - mice, h1L-4Ra Tg/mIL-4Ra</~ mice developed Thl cytokine and 
type 2 antibody responses during either L major or N. hrasiliensie)' infections, in the 
absence of hIL-4. Transgenic mice were unable to expel N. brasiliensis worms 
confirming unresponsiveness in non-lymphocytes. These results suggested that 
endngenous m1L-4 signaled through the chimeric receptor in hlLARfX Tg/mIL-4Ra+ 
mice in vivo. Neutralization of endogenous m I 1.-4 resulted in an inhibition of N. 
hrasiliensis-induced Th2 cytokine and total IgE production in transgenic mice. In a 
genetic approach, we depleted endogenous m1L-4 and mIL-13 by intercrossing hlLARa 
Tg/mIL-4Ra-l- mice with mIL-4-1-; mIL-13~/- mice. The absence of mIL-4 and I11IL-13 
completely abrogated type 2 responses in both N. hrasiliensis and L mujor infections. 
These data confirmed that the chimeric receptor responded to m1L-4 in vivo. However, 
hlL-4Rfl Tgi mIL-4Rex.-i - ImIL-4-1- ImIL-1 mice were susceptible to L. majnr infection, 
indicating that this mouse model could not be used in L major infection studies. 
Together, these data demonstrate that despite the unresponsiveness of the h1L-4Ral myc 
chimeric receptor to miLA and m1L-13 in vitro, the chimeric receptor responded to 
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LR. I Introduction to immunity 
Immunity (L. immun, safe, free of burden) is defined as the ability of an organism to 
protect itself against disease. This includes the identification and destruction of foreign 
substances or organisms but also of abnormal cells, such as cancer cells. The mammalian 
immune system consists of the innate immunity and the acquired or adaptive immunity. 
The innate immune response is the body's first line of defense. This type of immunity is 
present before exposure to pathogens and is especially important early in infections. 
Physical and chemical barriers such as the skin, acidic conditions in the gut and mucus 
and cilia in the airways are all components of the innate immunity. These exterior 
defenses prevent many infectious agents from entering the body. However, when entry is 
gained, cellular components of the innate immunity respond immediately to eliminate the 
invading organism. Cells of the innate immunity include granulocytes (cosinophils, 
basophils and neutrophils), monocytes/macrophages, dendritic cells (Des) and natural 
killer (NK) cells (Beutler, 2004). Pathogens are recognized by common structures, f{)r 
example bacteria contain "pathogen-associated molecular patterns" (PAMPs) such as 
lipopolysaccharide (LPS) and mannan. Innate cells can kill pathogens directly by the 
release of cytotoxic substances, or phagocytose organisms for intracellular killing mostly 
via free radicals and other toxic derivatives (Janeway and Medzhitov, 2002). 
The adaptive immune response is a highly specific response that recognizes particular 
peptide components (antigens) of pathogens or other cells. 'rhis involves antibody 
producing B lymphocytes, constituting the humoral immunity, and T lymphocytes which 
I<mn part of the cell-mediated immunity. B lymphocytes express specific antigen 
receptors on their surface, also known as immunoglobulins (I g) (Raghaven and 
Bjorkman, 1996). When an antigen binds to its Ig receptor, B lymphocytes develop into 
plasma cells, which secrete large amounts of the receptor in a soluble form (Calame, 
200 I; Dal Porto et aI., 2004). These receptor molecules are known as antibodies and 













antibody interacts with other factors of the immune system, thereby allowing these 
clements to recognize and destroy antibody-coated pathogens (Gessner ct aI., 1998; 
Monteiro and Van De Winkel, 2003; Hofer et aI., 20(6). 
T lymphocytes recognize antigens by a specific receptor termed the T cell antigen 
receptor (TeR) (Rudolph et aI., 2006). The TCR is structurally related to the surface 
receptors on 13 lymphocytes but does not bind free antigen as antibodies do. Antigens are 
only recognized when presented by host cells m combination with major 
histocompatibility complex (MHC) or CD] molecules. Mile molecules are polymorphic 
cell-surface molecules that bind antigens which have been degraded inside the cell. They 
are divided into MHC class 1 and class II molecules depending on the lype and source of 
the antigen presented (Watts, 1997; Crcsswel [ et aI., 2005; Stern et aI., 2(06). COl 
molecules are structurally related to MIle molecules but are not polymorphic and present 
lipid and glycolipid antigens (Brigl and Brenner, 20(4). Recognition or antigens by T 
lymphocytes causes the release of soluble proleins, called cytokines, or the killing of cells 
bearing the antigen. T lymphocytes and their functions are discussed in more detail later. 
There is a constant interaction, coordination and communication between the variolls 
parts of the immune system and most immune responses to invading organisms combine 
the componems hom both the innate and adaptive immunity. 
LR.2 Cytokines 
Communication between the components of the immune system is facilitated by the 
release of chemical messengers such as cytokines. Cytokines are low molecular weight 
proteins that control, coordinate, and regulate various immune or inflammatory 
responses. They are important for innammation, proliferation, differentiation of Band T 
lymphocytes and regulation of macrophage and lymphocyte functions (O'Shea ct aI., 
20(2). There are many cytokines and most of them have a multitude of functions. 'rhey 
include the ehemokines, interleukins, interferons, growth factors, colony-stimulating 
factors and tumour necrosis factors. Chemokines are mainly involved in directing the 
migration of cells around the body and activating specific cell types. Examples of these 












produced primarily by T cells and play a major role in the proliferation and 
differentiation of cells. Interferons, sLlch as IFN-a and IFN-f) are secreted by viraliy 
infected cells to induce resistance to viral infection in uninfected cells. IFN-y is produced 
by T cells and has a whole range of functions. 
Growth factors such as transfbrming growth factor (TGF) promote growth of fibroblasts 
and other cell types. Colony-stimulating factors mediate the proliferation and 
differentiation of mainly bone-marrow stem cells and leucocyte precursors but also 
macrophages and monocytes. Tumour necrosis factors like TNF-a and 'fNF-13 have a 
major role in cytotoxicity and inflammation. This nomenclature is based mainly on the 
first function described for each cytokine but most of them have a multitude of functions 
and may belong to more than one of these groups (Borish and Steinke, 2003; Steinke and 
Borish, 2006). Cytokines exert their eflects by binding to specific receptors and 
activating intracellular signaling pathways that will induce or inhibit transcription of 
cytokine regulated genes (Miyajima et aI., 1992; Ihle et aI., 1995). There are ['our major 
signaling pathways. The Ras/mitogen-activated protein kinase (Ras/MAPK) and 
phosphoinositide-3-kinase (PI-3-kinase) pathways are both important fbr cell 
proliferation and prevention of apoptosis (Leonard and O'Shea, 1998; Dong et aI., 2002; 
Deane and Fruman, 20(4). Cytokines like IL-2. IL-3, IlA, IL-5 and GM-CSF activate 
these pathways, Signal transducer and activator of transcription (STAT,) pathways 
stimulate gene transcription by activati cytoplasmic transcription factors. Receptor 
associated kinases such as Janus kinases OAKs), phosphorylate different transcription 
factors (STATs 1-6, NF-IL6, NFKf3) resulting in their translocation to the nuclells and 
activation of genes (Hebenstreit et aI., 2(05). Another major group of pathways are those 
that lead to cell death. Members of the 'rNF family likeTNF-Cl, TNF-f), Fas ligand, CD40 
Ligand and TRAIL are especially important in the activation of these pathways 
(Aggarwal,2003). 
Some cytokincs share receptor subunits and this partly explains their functional 
redundancy. Understanding the roles of individual cytokines and the impOltance of 
cytokine expression profiles Ibr the outcome of disease has been a major undertaking in 
the scientific world. The use of gene-deficient (knockout) and transgenic mice has 













19(8). We now make use of mice that are deficient for cytokines or their receptor 
subunits, mice that are double. triple or even quadruple gene-deficient and more recently 
mice with cell-specific deletions or lransgenes. 
LR.3 T lymphocytes 
All T lymphocytes express CD3 surface marker and are divided into two major 
subpopulations: cytotoxic T (Tc) cells and T helper (Th) cells (Woodland and Dutton, 
2003). Tc cells, which are identified by their expression of CD8 (CDR\ specifically 
recognize antigenic peptides in combination with MHC class I molecules. The 
recognition or nJreign peptides such as virus particles presented by MHC class 
molecules will stimulate Tc cells to destroy infected host cells. Killing is mainly 
mediated by the release of preformed cytotoxic proteins such as perforin and granzyme, 
or the induction of apoptosis due to binding of Tc cell Fas ligand to Fas on host cells 
(Wong and Pamer, 2003; Russel and Ley, 2(02). 
On the other hand. l'h cells, which express CD4, recognize antigens associated with 
MIlC class II molecules. These molecules are largely present on immune cells such as B 
cells, dendritic cells and macro phages and present peptides which have been internalized 
and degraded by the cell. Upon stimulation the T helper cells produce cytokincs that 
inhibit or activate responses in immune effector cells. CD4+ T helper cells can be mainly 
subdivided into l' helper I (Thl) and T helper 2 (Th2) cells (Mosmann et aI., 1986b; 
Romagnani, 1996b). Both Thl andfh2 cells originate from the same naYve I L-2 
producing C04+ T cell precursors and differentiation of TCR stimulated C04+ T cells is 
mainly controlled by the cytokine environment (Fernandez-Botran et aI., 1988; Sad and 
Mosmann, 1994; Swain et aI., J988). Exposure to IL-12 and IFN-y will lead to Th I 
differentiation while I L-4 induces Th2 differentiation (Hsieh et aI., 1993; Swain et aI., 
19(0) (Figure A). Other tllctors that influence T cell d iffercntiation incl ude the amollnt 
and type of antigen (Holland et aI., 2000). the antigen presenting cell present (Ron and 
Sprenl, 1987) and co-stimulatory molecules (Dubey el aI., 1995). 
Th I cells secrete interleukin-2 (11.-2), lymphotoxin and interferon-y (IFN-y) which are 














as Leishmania major and Mycobacterium tuberculosis (Cherwinski et aI., 1987). Some of 
the effects mediated by Th 1 cells are delayed type hypersensitivity (Cher and Mosmann, 
1987), activation of macro phages, Tc and NK cells, and production of IgG2 antibodies 
(Stevens et aI., 1988). Th2 cells produce IL-4, lL-5, IL-9 and IL-13 which are important 
for protection against extracellular parasites such as Nippostrongylus brasiliensis and 
Trichinella spiralis. The cytokines produced by Th2 cells mediate type 2 immunity that is 
characterized by enhanced JgG 1 and IgE antibodies, infiltration of mast cells and 
basophils and eosinophilia (Katona et aI., 1988; Romagnani, 1996a). The roles of IL-4, 
IL-13 and their receptors in type 2 immunity forms a central part of the studies presented 
here and is therefore discussed further in the following section . 
IL-12 ....__ 
($1AT4) 
IL-<1 - --, GATA3 








Figure A. Regulation of Th cell development. 
l\Iaive CD4+ T helper (Th) cells can differentiate along the Thl or the Th2 pathway . 
Interleukin-12 (IL-12) and interferon-y (IFN-y) are important for Thl cell 
differentiation, while IL-4 is required for Th2 cell differentiation. IL-12 acting via the 
signal transducer and activator of transcription 4 (STAT4) induces IFN -y production. 
IFN-y promotes expression of IL-12 and the IL-12 receptor (IL-12R), and also 
activates Thl ceil-specific transcription factor T-bet, which, in turn, upregulates 
expression of IFN-y. On the other hand, IFN-y inhibits the Th2 pathway by 
suppressing IL4 gene expression through the interferon regulatory factors IRFl and 
IRF2. IL-4 signaling through STAT6 induces the Th2 cell-specific transcription factor 
GATA3 (GATA-binding protein 3). In turn, GATA3 regulates the expression of a range 
of Th2 cytokines but suppresses Thl cytokine expression through repression of IL-12 
signaling. The IL-4R-STAT6 and the IL-12R-STAT4 signaling pathways can 
downregulate expression of IFN-y and GATA3, respectively, thereby promoting one 
response by inhibiting the other response. DC, dendritic cell; LT, Iymphotoxin; TCR, 
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while suppressing the production of IgM, IgG2a, IgG2b and IgG3 (Coffman et al., 1986: 
Snapper et a1., 1988; Vitetta et aI., 1985). It enhances the generation of basophils, mast 
cells and eosinophils from progenitor cells (Favre et aI., 1990; Rennick et al., 1987) and 
activates neutrophils for the killing and phagocytosis of opsonized cells (Boey et ai., 
1989). IL-4 inhibits the production or lL-I, IL-6, I L-8 and TNF by mOl1ocytes while 
stimulating the production of G-CSF and M-CSF (Essner et ai., 1989; Miossec et al., 
1992; Standiford et aI., 1990; Wieser et aI., 1(89). On T cells, it plays an important role 
in the development of antigen-specilic cytotoxic cells (Horohov et aI., 1988) and, 
importantly, promotes the differentiation of na'lve CD4 i T cells into the Th2 phenotype 
(Le Gros et aI., 1990; Swain et aI., 19(0). 
LR. 4.2 Interleukin-13 
13 is a 10-14 kDa pleiotropic Th2 type cytokine belonging to the same a helix 
superfamily as IL-4 (Brown et aI., 1989; McKenzie et aI., 1993a; Minty et aI., 1993). 'fhe 
human IL- J 3 gene is located on chromosome 5q3J only J 2 kb distal from the IL-4 gene. 
The mouse IL-13 gene is found on chromosome 11 together with the genes for IL-3, I 
4, 11,-5 and GM-CSF (Boulay and Paul, 1992; McKenzie et aI., 1993b; Smirnov el al., 
19(5). IL-13 is produced by T cells, NK eel mast cells, basophils, eosinophils and 
dendritic cells (Hoshino et aI., 1999; McKenzie et ai., 1993a). IL-4 and IL-13 have only 
about 25% homology but share many functional properties. IL-13 up-regulates MHC 
class II, CI)23 and C080/86 on monocytes and macrophages and inhibits monocytes 
production or proinllammatory cytokines and chemokines (de Waal Malcfyt et aL, 1993; 
McKenzie et 1993a; Punnonen et at., 1(93). In addition, it induces vascular cell 
adhesion molecule (VCAM)-l on vascular epithelium to direct migration of lymphocytes, 
monocytes, basophils and eosinophils to sites of inflammation (Bochner et a!., 1995; 
Ying et ai., 1997). I 13 also has distinct functions. Unlike IL-4, it does not int1uence 
dillerentiation or S'rAT6 activation in T cells (de Waal Malefyt et aI., 1995; Minty et aI., 
1997; Zurawski et ai., 19(3). Whereas 1 behaves similarly in human and mouse B 
cells, IL-13 acts differently in these species. In human B cells, IL-13 induces class 
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Figure B. IL-4 and IL-13 receptor complexes 
Literature Review 
IL-4 interacts with the IL-4Ra subunit in combination with either yc (Type I IL-4R) or IL-13Ral 
(Type II IL-4R). IL-13 interacts with IL-) 3Ral in combination with IL-4Ra or with IL-13Ra2. 
Increasing thickness of the arrows indicate increasing binding affinities (Kd) (Adapted from 
Brombacher, 2000) 
The type I receptor consists of the common IL-2Ry chain, yc and the 140 kDa IL-4Ra 
subunit (Mosley et aI., 1989; Russell et aI., 1993). The yc is also shared by the receptors 
for IL-2, IL-7, IL-9 and IL-15 (Giri et aI., 1994; Noguchi et aI., 1993; Russell et aI., 1994; 
Takeshita et aI., 1992). Neither the IL-4Ra nor the yc, separately or together binds IL-13 
(Vita et aI., 1995). The type I receptor is expressed predominantly on hematopoietic cells 
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molecule recruited to the phosphorylated I L-4Ro: are latory 















20(3) and the insulin receptor substrate (IRS) family (Jiang et ai., 2000). IRS proteins 
become phosphorylated and can associate with cytoplasmic signaling molecules such as 
phosphatidylinositol 3-kinase (PI3K) which is important for growth and regulatory 
signals through the IL-4Rct (lzuhara and Harada, 1993; 19(6). 
LR. 4.5 Species-specificity 
Murine and human IL-4 display about 60% amino acid homology and mediate similar 
effects on T cells in their respective species (Lee et a!., 1986; Yokota et a!., 1(86). 
Furthermore, the receptors for these two proteins share about 53% homology (ldzerda et 
al., 1(90). Despite this homology the binding of murine and human IL-4 to their 
respective receptors is species-specific (Lowenthal ct 1988; Nakajima et al., 1987; 
Ohara and Paul, 1987; Park el aI., 1987a; 1987b). Human cell lines are able to respond to 
human IL-4 but not mIL-4, while mouse cell lines do not bind hlL-4 but respond to mlL-
4 (Mosmann ct aI., 1(87). However, hlL-4 is able to bind to receptors on monkey cdl 
lines (Park ct aI., 1987b). The expression of h1L-4Ra in a mouse cell line confers 
responsiveness to h1L-4 indicaling that hI tARn is able to form a functional receptor with 
mouse ing components (ldzerda et aI., 1(90). Later it was demonstrated that murine 
"Ic can complex with either mlL-4Rrt or hll ,-4Ru to ftJrI11 a functional type I receptor 
(Andrews ct aI., 200 I). The same does not hold true for the type II receptor: the 
interaction between lL-4Ru and IL-13R(1I is species-specific. In murine B cel 
transfecled hIL-4RcL was 110t able to associate with mlL-I3Rcd to form a functional tL-
13 R. whereas transfection of both hi L-4Ru and hi L-13Ra 1 rendered cells responsive to 
IL-I3.lnterestingly, IL-13 itsclfis not species-specific and both human and murine IL-13 
can signal through receptors of the other species (McKenzie et aI., 1993a). However, 11.-
13 is species selective because although mouse IL-13 will act equally on mouse and 
human cells, human IL-13 has a greater effect on human cells than on mouse cells (de 
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LR.5 Leishmania major 
LR. Brief history of Leishmania 
Leishmania is the causative agent of the disl~ase leishmaniasis. It was first discovered in 
1903 in the spleens of patients with malaria-like symptoms and named as Leishmania 
donovani after its separate co-discoverers William Leishman and Charles Donovan. The 
protozoan parasites are transmitted by the sandfly vectors Phlebotomus (old world) or 
Lutzumyia (new world) which become infected with Leishmania when feeding on the 
blood of infected individuals or animals (Figure C). The Leishmania parasites live as 
amastigotes in macrophages but transform into moti Ie flagellate promastigotes when 
released in the stomach of the insect (Killick-Kendrick, 1(90). When the sancHly takes 
another blood meal, the mctacyclic promastigotes are transferred into the skin of the host. 
The parasite promastigotes bind to host macro phages via surface molecules such as the 
complement receptor I and 3. mannose fucose receptor, the Fc receptor and the 
tihroneclin receptor (Channon et al., 1984; Da Silva et £11., 1989; Guy and Belosevic, 
1993; Lockslcy et aI., 1988; Ouaissi, 1988; Wilson and Pearson, 1986). The organisms 
are internalizcd into phagosomcs which fuse with Iysosomes to form the macrophage 
parasitophorous vacuole. Here, the parasites transform into replicating intracellular 
amastigotes and continue to spread to uninfected cells (Alexander and Russell, 1992; 
Antoine et aI., 1998; Desjardins and Descoteaux, 1(98). 
The different species of'the genus Leishmania produce a wide range of diseases differing 
in severity (Ilerwaldt, 1999; Pearson et aI., 1(83). In visceral leishmaniasis. caused by 1.. 
donovani, the parasite disseminates to spleen, liver and bone marrow. Cutaneous 
leishmaniasis is characterized by localized lesions with the parasites remaining in the 
cutaneous lesions and draining lymph nodes. This form of leishmaniasis is caused by L. 
/ropica and 1.. major in the old world while L mexicana, L amazonensis and L 


























• Divide in midgul and 
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. ;;: Infective SI8ge 
A = Diagno$bC Siage 
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(Injects I)r'Cm8st9Ole stage 
InlO lhe skin) 
Figure C. Life cycle of the Leishmania species 
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Human Stages 
e Promastigotes are 
pl\agocytized by --goo" 
• Protmal.tigc)tes transform 
into amastigotes inside 
macrophages A 
J 
Leishmania paraSites are transmitted by female phlebotomine sandflies. The 
sandflies inject the infective stage, promastigotes, into the skin of the host 
during blood meals . Promastigotes inside the skin are phagocytized by 
macrophages . and transform into amastigotes . . Amastigotes multiply in infected 
cells of various tissues depending on the Leishmania species e. Sandflies become 
infected when they ingest amastigote-infected macrophages during blood meals on 
an infected host (0 , 0 ). Amastigote paraSites differentiate into promastigotes in 
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Table A. BALB/c susceptibility to different Leishmania major substrains 
L. major substrains are indicated as follows: Seidman (WHOM/SN/74), FEBNI 




IL-4-1- IL-13-I- IL-4Ra -1- Note Lab Reference 
strain IL-4 STAT6 -1-
Seidman yes Muller 
Kropf et aI., 1997, 
1999,2003 
FEBNI no Gessner Debus et aI., 2003 
no Kopf et aI., 1996 
no Muller Kropf et al., 2003 
Friedlin reduced Sacks Belkaid et aI., 1998 
reduced Sacks 
Noben-Trauth et aI., 
2003 
no no Staudt Dent et aI., 1999 
IR 173 reduced reduced no 
t parasite 
Sacks 
Noben-Trauth et aJ., 
load 1999,2003 
--- ---
reduced Locksley Heinzel et aI., 1989 
no Locksley 
Sadick et aI., 1990, 
1991 
no Locksley Wakil et a!., 1996 
--
no Locksley Stetson et aI., 2002 
no Coffman 
Chatelain et a!., 1992, 
1999 
no Coffman 
von der Weid et aJ., 
1996 _.'. 
Maier 
Heinzel & Maier 
no no 1999 
---
no Reiner Brown et aI., 1996 
LV39 no no no McKenzie Matthews et aI., 2000 
reduced reduced 
t parasite 
Brombacher Mohrs et aI., 1999 
load 
reduced yes yes Sacks 
Noben-Trauth et aI., 
1999,2003 
reduced yes Muller 
Noben-Trauth et aI., 
1996 
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indicating that IL-4Ru signaling in other cells plays a role in later susceptibility (Holscher 
et aI., 2006). 
















a. Priming by IFI\J-y followed by a microbial trigger (lipopolysaccharide, LPS) results 
in classical activation of macrophages. b. Alternative activation is mediated by 
interleukin-4 (IL-4) and IL-13, signaling through the common IL-4Ru. DTH, delayed-
type hypersensitivity; MR, mannose receptor; NO, nitric oxide; TNF, tumour-necrosis 
factor (Gordon, 2003). 
IL-IO acts differently on macrophages to IL-4 and IL-13. It downregulates MHC class II 
expression , NOS2 activity and the release of pro-inflammatory cytokines by classically 
activated macrophages (Donnelly et aI., 1999; Montaner et aI., 1999). Treatment of L. 
major infected macrophages with rIL- IO results in the suppression of IL-12 and TNF 
production as well as failure to control parasite growth (Kane and Mosser, 200 1; Vieth et 
aI., 1994). In this regard the IL-IO induction by amastigotes (as discussed earlier) may be 
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Table B. Parasitic helminth infections in humans 






Schistosoma haematobium Schistosomiasis 200 
Schistosoma japonicum 
I Cestodes (tapeworms) Tapeworm 10-30 
Nematodes (roundworms) 
Trichuris trichura Trichuriasis 604-795 
(whipworm) 
Ascaris lumbricoides Ascariasis 807-1221 
Trichinella spiralis Trichinosis 70-90 
Ancylestoma duodenale 
Necator americanus Hookworm 576-740 
Wuchereria bancrofti 
Lymphatic 
Brugia malayi 70-90 
Dipetalonema perstans 
filariasis 
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on et at., 200 I). 
required for elimination of worms. Studies in rats 
provided 
worm 
for a chronological 
et aI., 1994). 
and 
alterations in 
I L-13 have on non-bone marrow derived Is. IL-4 and 13 
cell 
el a1., all contribute to worm expulsion 
to prostaglandin 
(Madden et 
and I L-I 3 on protease 
smooth 





involved In protection. 
These 
goblet cell and worm 
(ilorsnell ct al not published). 
as 
more recent uated 
I (PAR-I). receptor is 
iaL nerve and propria Is and 
2002; 
in the 
hyper-contractility et 2005). It 
is more critical worm or 
]3 to the worms. Currently, 
in I on one or 
made from these mice should shed more 
with smooth 
cells playa III 
to expel N. worms 

















LR. The role of other '>"TAIE]'" 
expulsion 
I 1,-9 are also 
Review 
and molecules worm 
cells in 
that they may play important roles in host 
to N. brasiliensis 




et aI., I Although I 
mice showed 
III lia a III worm 
worms 
intestine. The 
cytokine in protection to brasiliensis was the use of mu 
showed a delay in worm 
was observed for I 
mice. Animals IL-4, 11,-13 and I 
to IL-4/1 A similar add 
with ILA/I 
et aI., 2000). 
The Th2 
Trichuris muris 
















sLich as Heligmosomoides polygyrus and 
11B7-2 co-stimulatory (Greenwald 
20(0). In 
( 
treatment resulted in 
lity to expelled N. 
lL-4 and IL-
worms (Harris et 
Taking into account the role of Th2 cytokines protection to N. infection. it 
is not Th I 
the 
due to 
is mostly but not rcversed by 




















Rcq uirements Th2 development during N. brasiliensis infection 
A for I in was using I or 
mice (Kopf et 
of 1'112 
1993; Takeda et a1., 19(6). In these 
by CD4' T Is 
reduced but not completely 
with I producing independent of I 
Th2 production is more severely 
IL-13 a role in Th2 
II I et aI., 
]3 is not required for 
Contrary to the reduced lia in IL-4-1-
mice eosinophilia 
cell (U rban et aI., 
demonstrate some with 






et aI., I 998a). 
STAT6'/" 
"'''''''c''' mucosal mast 
develop 
et 











the same study it was shown that 
NKT cells to Class I 
cells and that 
injection of 










of B Is or 


















Is but that cytokines were required of to 
et aL 
6.3.4 Antibody production in response to N. brasiliensis infection 









contribute to damage 
1985b). 
to worms coated with 
contents onto the of the worms (Kojirna et 
antibodies 
and of these in 
giant lungs of infected 
aI., I T cell 
the 












(Katona ct aI., 






on IL-4R!1 on 
T cells (Urban et 
observed in CiA TA3-
13 in I production. 
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IS 
production of IL-4!1 13 by 
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Materials and Methods 
Materials and Methods 
MM.I Mice 
All experimental were under specific 




background and more than 10 generations. 
4Ro.Tg/mIL-4Rc(l- mice were Dr. Masato Kubo of the 
for 8iological Sciences. Japan 20(4). 8A LBIc. 
hIL-4RflTg/ml Ro.-1-; m were obtained 
''''CIf''''''', Institute of Molecular Medicine, 
(Matthews el aI., 2000; Mohrs et All 
A Board 
A 
MM. 2 Genotyping of genetically modified mice 
of all genetically modi 
(peR) of DNA obtained 
conditions: 94°C/I 
were confirmed by the 
PCR reactions were 
seconds. 
on an MJ 
water 








Town. The primers 



















to inject 8 m' 
by a 
peritoneum. A 
and the peritoneum was massaged. 
a an 18G Ie (B.Braun, Melsungen, 
nodes Iyand 
iel and single 












minutes buffer. A I iquots of Is (l O~tl) were 
to determine 
111 
counted on a Neubauer cell 













In lOOul of buffer inactivated rat serum and 




mAb (M~I, Inc. Oaks, gin from F. Oil), 
biolinylaled mouse anti~human IL-4Ru mAb (hll 
or biotinylated mouse [gG I control 1, 
CA). cells the dark at and 
AL) to mAb and streptavid San 




Louis, MO) in 500~d 
with C 
500~d bu rrer. 
lymphocyte populations 





dark at 4°C 
(Sigma, 
T ceils, cells were blocked as described and 
South 
Ie 200 000 
were 





MM. 4 Cell proliferation assay 
NaYve were 
in 




















Materials and Methods 
were fi through 70 nylon cell (Becton-
Dickinson, contam i nated in 
Iy I heat The 
for 1 0 minutes and IIMDM 
AI Is (IOlll) were diluted in 
counted on a of 
viable Is were determined dead I volumes 
were adj LIsted to cell concentrations or cells ImL PMA (Sigma) was to 
group 
Nunc 
cells at I 








2000ng/ml 200ng/ml rhl (gin from Dr. Masato 
(BD 
400ng/ml 
rI 13 (R&D Minneapolis, MN). A dilutions were 
!um alone was each mulant in 1M 10%FCS. 
row cells at I Is were for at 
to a 
a 
humidified C02 incubator. CHj-thymidine (AI--:C Amersham, was 
cells were 
was dried, 
in 20~tl at well 18 




amount of thymidine 
(cpm) for stimulant di 
MM.5 T cell differentiation 
were by 
COUllllXf in a ~ liquid Ilation counter to 
Its were rOT,~~r,,,i to as counts 
dislocation. Lymph nodes were 
and placed in ice RPMI ]640 supplemented 10% (G Life 
Paisley, UK). Single were 
Is 
blood III iRed underlayed carefully with 

















in 2ml RPMI 1 Aliquots Is (1 O~lI) were di 
and counted on a 
by magnetic 
(M The 




per well in 






cells were incubated with 12 (BD Pharmingen) 
(1 J B II). polarization was by 
Phann and 50ng/ml mouse I (BD 
Minneapol MN) or IOOng/m! human I 
Medium alone was added the condition. The 











ell hurl ng, ce II s 
it 













48 hours of stimulation 



















Materials and Methods 






at 1200rpm at 
per ml in a volume of I 
U incubated 
cells were and the Is washed 2 
DMII 0% 'rhe adherent were incubated 16 
lum, I OO~tI rl L-4 ( IOOOlJ/ml, HD Pharmingen) or lOOpJ 
R&D The Is were stimulated I OO~ll of 










in a C02 at 1200rpm 10 
at il1atlol1. 
remal resuspended in 50111 of (). 1 X-IOO. 
on a at room well 





oxide (NO) in 
(Oswald et aI., 1992). 
dilutions were from a 2mM ulion in IMDM 




Solution I (I 
in IMDM and 
DM to turn low. 
1 %napthyl-ethylene-diamene in phosphoric 
NO indicated a 

















MM. 6.3 Measurement of 
I activity in 
aI., , 
pH were added 
pH the activated 
Materials and Methods 
activity 
as previously 
IOmM MnCh. SOmM 
was activated 10 minutes a1 
addition of 
samples were incubated at 




of I-bO (I :3:7). Aliquots 25~d freshly made 9% ISPF dissolved 




I of urea in I-hO. 
the acid 
at 540nl11 in 
Sunnyvale, 




was used as a measure of ity. 
MM.7 ELISA 
International, 
were obtained BD 
overnight at 
were washed once and 
with 200jJi Blocki Three-fold dil of 
dilution buffer an undi sample to a 1 
either IOOng/ml or were di 
were washed 4 and 50~Ll diluted 
were incubated overnight at 
corresponding biotinylaled 
at 3 
4 times. For 



























(1/1000 dilution) or d'O(J·nt<t 
to the wells. A 




was used the 
495nm on a 
lar SlInnydale. CA. USA). 





(MRHO/Sv/59/P-strain) and (MHOM/ILl81 
were maintained by 







mice heal lymph In 
ass{~ss curve. 
MM. Preparation L. major 
at 
in 






I week at room 
and were daily to 
were in of 
was 
,,,,,,,n"f1 twice 












Materials and Methods 
MM.8.3 I of mice 
was carried out in an Animal Biosafety 2 Laboratory. 
were 
IOOmg/ml 




parasites in a 
left hind 
of 50111. 
MM.8.4 Footpad measurements 
was the both infected 
uninfectcd footpads using a Mitutoyo micrometer iper (Japan). The footpad 
(mm) was by footpad (mm) the uninfccted 
footpad from the left measurements were out from 
were 
MM. Quantification of parasite burden 
lim was to 
individual m I suspensions were 
were resuspended in 6.4 ml Schneider's 
U,"Hl-n"J.~ were weighed 20% The individual 
medium using an 
made in 
the L major 
from the cells 
tum (Sigma) supplemented with 




The plates were incubated in a humidi 
insect medium supplemented 
chamber at for~7 
which each well was microscopically 
the number L. major 
- 49 -
for parasite 















Materials and Methods 
footpad were calculated from the single hit Poisson model equation using the l 
minimization method as described previously (Kropf et al., 20(2). 
MM.8.6 Preparation of L. major soluble antigcn 
Stationary phase L. major parasites were prepared as described in M M 1 Culturing of 
L. major. 'rhe culture medium was washed three times by centrifuging at 2500 rpm for I () 
minutes and resuspending the pellet in 10mi PBS. After the last wash, the L major pellet 
was resuspended in 2ml PBS and cOLinted to determine the parasite concentration. The 
suspension was rapidly frozen in liquid nitrogen and thawed at 37°C ten times. After 
ensuring that the sLispension contained no moti Ie parasites, the freeze-thawed (FIT) 
antigen preparation was frozen at -80°C until required. 
MM.8.7 Rcstimulation oflymph node cells 
Mice were sacrificed at the desired time points hy cervical dislocation and the draining 
popliteal lymph nodes collected in ice cold IMDM supplemented with 10% rcs 
(IMI)M/IO!%FCS). Single cell suspensions were prepared by straining the cells through 
metal sieves, Contaminating red blood cells were removed by resuspending cells in 5 ml 
Red cell lysis buffer and underlaying carefully with 2m! heat-inactivated FCS. The cells 
were centrifuged at 1200rpm at 4°(: for 10 minutes and resuspended in 2ml 
IMDMII O!%FCS. Aliquots of cells (I Ofll) were diluted in Trypan Blue and counted 011 a 
Neubauer haemocytometer to determine the cell concentration of non-stained v iabJe cells. 
The cell volumes were adjusted to cell concentrations of I xl Oh cells/ml in 
IMDM/J O%FCS and triplicates of 500~tI of cells were plated in flat bottom 48 well plates 
(Costar). For anti-CD3 stimulation, wells were precoated overnight at 4°C wilh 20flg/ml 
anti-CD3 (clone 145-2C 11) in PBS and the antibodies removed bef()fe adding cells. For a 
control PBS was used to coat wells. The plates were incubated at 3rc fi)f 72 hours in a 
5%) CO2 incubator. Supernatant were removed and aliquots of I OO~t1 frozen at -80°C for 
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Materials and Methods 
8.8 Leishmania-specific ELISA 
Is of under an light a 
was made aeross leeted in microtainer serum 




antibodies of all points 
I, and was measured to determine 
plates were coated with I IC) in 
were times with incubated overnight a1 4°C 
200~tI Blocking blocking, 4 times 50111 of the 
in dil in Dilution 111 0 to 1/1 
the 
(BD Pharmingen) were added in 
incubated 
in Dilution buffer 
405nm and 
CA, USA) 
at 1/10 and 
plates were 
a 1:1000 dilution 
with polyclonal alkaline was 
added to the After incubating at 3 for 3 
and p-nitrophenyl (I mg/ml) 
added. 'file of 
(Molecular 













Materials and Methods 
MM. 9 Nippostrongylus brasiliensis methods 
MM.9.1 Cultu of N. IIIlJ'."" 
hrasiliensis worms were routinely in Witstar rats. were 
prepared in 0.9% at 10 000 worms ml. to rats were 
subcutaneously in the flank 
5 of 
and the bottom of the 
pellets from infected rats were 
post in MilliQ water 
it to act as 
fi 
""''''''\\!I>rt and transferred to for 
MM.9.2 Preparation of worms and infection 
filter 
worm solution 
rats were n'''''C'lr'''',rA/1 





until worms were 
larvae were p'",,",,",u in water 10 
to dislodge worms. The worms were counted a a 
mixed to 
out in an Animal 
worms in a 
in solution was continuously 












MM. 9.3 collection and counts 
mice were 
were cleaned 
fi:lllowing day. The 
Materials and Methods 





(Advanced were soaked in :'vtilliQ water 
to emulsify 
mixed for 5 
of each sample to c 
The aliquots were 
of the Master slide. Aller 
both of the etched areas on the sl ide. The 
was 0.1 thus a 10tal volume of 0.3011 was 
in the two chambers was divided by 0.3. multipl 
of to the 
M:vI.9.4 intestinal worm counts 
emulsion was 
of 2ml was taken from 
were included. 
to both 
were counted under 
The total number of 
by and l1nally divided by 
were sacrificed on 7 or day 14 infection cervical .... ,.,."J\.,' .. 'Vll. 
individual were removed III 50ml 
were split longitudinally, on 
in the same I. The were incubated at fi)r 4 hours to 





of mesenteric lymph node cells 
lymph nodes were under sterile 
111 IMDM 10% (lMDMII 















Is were at 1200rpm 10 
IMDM/l0 IrIIFCS. Aliquots of cells (l0/-1I) were di in Trypan 
in 2ml 
Is 




MM. 9.6 treatment 
system as instructed by the manufacturer (M i Itenyi 
was used to conl1rm that purity the Is 
Is were IMDM/I Fes at a 
triplicates 
were 







(IIBII, rat I) was diluted in PBS to lmgimL 
were injected intraperitoneally with 1 of at I before and 







until antibody analysis 
at 7 and day 14 p.i. from 
points were measured 
an light and a 
at 4500rpm 15 minutes and 
from 
of all 
IgGI, I were measured to determine responses 
Inc, 
at 50~tl per to 96 well 
(Southern Biotechnology 
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Materials and Methods 
). were overnight at washed once and 200~1 B 
blocking overnight at plates were 4 50ul 
or eli standards Samples were eli 3-fold in Dilution 
from 1/100 for isotypes 13 Inc, 
AL 
standards were diluted 
plates were im;ubated 














50~1 added to wells. 
of p-nitrophenyl 
































1.1 Generation of lymphocyte-specific h1L-4Ra Tg/mIL-4Ra-l - mice 
IL-4 a key in the na'ive 'I' Th2 in vitro 
1990; Murphy and IL-4 acts via 
In 
turn IS Th2 phenotype 
et al.. J 997). R 
activation commitment hIL-4Ra under 
a lymphocyte-specific intronic 
et al., 2004). 
with mouse yc to a functional I I that is responsive to hi L-4 
( et al 1990; 
the chi meric receptor 
manner (Mosmann et at., I 
IL-\ I in mouse 





receptor in a 
lack 
with mlL-
et aI., 20(1). 
background more than 10 
were mIlARa-!' 1999) to lymphocyte 
(Fig. I). thus 
the chimeric In lymphocytes while completely deficient 
Il1 endogenous 
novel mouse mode! provides LIS with an to 
study the 
d 

















hIL-4Ra Tg ImIL-4Ra -1-
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type I IL-4R 
\) 
- No type I or type n 
IL-4R 
Figure 1. Generation of lymphocyte-specific hIL-4Ra Tg/mIL-4Ra-l- mice 
Transgenic BALB/c mice expressing lymphocyte-specific hIL-4Ra. were intercrossed with mlL-
4 Ra.-I - mice to generate lymphocyte-specific hIL-4Ra. Tg/mI L-4Ra.-I - mice. Lymphocytes from 
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I Genotyping 
To discern "'fnnI0"Y'i hi Tg/mIL-4Ru-l -
were 
111 was determined by 





a mIL-4Ra J• mouse exons 
7, 8 9 the m I are The forward 








reverse primer in ex on 8 in a 600bp 
mouse containing exons. On the other the 
In exon 10. 
using DNA from ml a 
3000bp between exon 6 and lOin a wild-type mouse is too 
hi 
the other hand, al 
the 





mIL-4Ra- l . 
{>n'YlP'H was not 
control in both 















knockout allele wild-type allele 
}\ r------------~------------~ ~~----------~----------~~ 
2 3 4 5 6 789 to It 12 13 14 15 !ll! 
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Three peR reactions were used to identify h1L-4Ru Tg/mIL-4Ru'/' mice, A. peR reactions using 
primers to the 600bp wild-type allele and primers to the 471 bp knockout allele, Lanes 1, 2, 9 and 
10 contain peR products from WT BALB/c mice, Lanes 3, 4, 11 and 12 contain peR products 
from hIL-4Ru Tg/mIL-4Ru'/' mice while lanes 5, 6, 13 and 14 contain peR products from mIL-
4Ru'/' mice, A DNA marker was loaded in lane 8 and the negative controls for each reaction in 
lanes 7 and IS, B. peR reactions using primers to the h1L-4Ru transgene. Lanes 1 and 2 contain 
the peR products from WT BALB/c mice, lanes 3 and 4 contain peR products from hIL-4Ru 
Tg/mIL-4Ru'/' mice and lanes 5 and 6 contain peR products from mIL-4Ru'/' mice. A DNA 
marker was loaded in lane 8 and a negative control in lane 7. The sizes (in bp) of the DNA 
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Results 
1.3 Analysis of cell surface expression of mIL-4Ra and hIL-4Ra 
The cell surface expression of mIL-4Ra and hIL-4Ra was analyzed using four colour 
flow cytometry to verify that transgenic mice express lymphocyte-specific hIL-4Ra but 
no mIL-4Ra. Different cell populations from nai've lymph node, peritoneal exudate cells 
and splenocytes were identified by staining with fluorescence labeled antibodies to 
various cell surface molecules. The correct isotype controls for these antibodies were 
used to ensure their specificity. Cells were further incubated with 7-AAD or propidium 
iodide to ensure the analysis of viable cells. mIL-4Ra surface expression was absent on 
CD3+, CD4+ or B220+ lymph node cells from hIL-4Ra Tg/mIL-4Ra-l - similar as mIL-
4Ra-l- strain compared to BALB/c positive control (Fig. 3). 
To confirm that transgenic mice express lymphocyte-specific hIL-4Ra, lymphocyte and 
non-lymphocyte subpopulations were analyzed for expression of this receptor subunit. 
An isotype control antibody was used to verify the specificity of the anti-hIL-4Ra 
antibody and function as negative control. BALB/c and mIL-4Ra-l - strains were included 
as additional negative controls. CD3+CD4+ (Fig. 4A) and CD3+CD8+ (Fig. 4B) T cell 
subsets expressed hIL-4Ra in the hIL-4Ra Tg/mIL-4Ra-l- strain. Of the CD3+CD4+ cells, 
62% were positive for hIL-4Ra expression while 69% of CD3+CD8+ T cells expressed 
the subunit. A smaller NK-T cell subset (data not shown) with high CD3 and CD49b 
(DXS) expression showed hIL-4Ra expression as did 37% of CD 19+ B cells (Fig. 4C). 
For surface expression in non-lymphocytes, macrophages, NK cells, dendritic cells (DC) 
and granulocytes were analyzed. MHC rr F4/80+ (Fig. SA) and MHC II+ F4/80+ (Fig. SB) 
macrophages showed no expression of hIL-4Ra. CD3- DXS+ NK cells (Fig. SC) and 
MHC II+CD II c + DC's (Fig. SO) were mostly negative for hIL-4Ra expression but 9% 
and 8% of each respective gated population expressed the receptor subunit. GR-I + 
CD I I b + granulocytes (Fig. SE) showed no expression of hIL-4Ra. Cells from BALB/c 
and mIL-4Ra-l - strains had no h1L-4Ra expression in any of the lymphocyte or non-
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Figure 3. Surface expression of mIL-4Ra on lymphocytes. 
Lymph node cells were isolated from na"ive BALB/c (black line), hlL-4Ra Tg/mIL-4Raolo (green 
line) and mIL-4Ra
olo 
(red line) mice and analyzed by FACS using various cell surface molecules. 
Whole lymph node (LN) cells, CD3+ T cells, CD4+ T cells and B220+ lymphocytes were 
examined for the expression of mIL-4Ra. Cells were pooled from 3 mice per group with results 
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Figure 4. Surface expression of hIL-4Ra on lymphocytes. 
hIL-4Rtl Tgi mIL-4Rt1 ./. 




Lymph node cells were isolated from narve BALB/c (black line), h1L-4Ra TgimlL-4Ra·l. (green 
line) and mIL-4Ra·l . (red line) mice and analyzed by FACS for the expression ofhIL-4Ra. Cells 
from hlL-4Ra TgimIL-4Ra·l • mice were stained with the appropriate isotype control antibody 
(blue line). CD3+CD4+ and CD3+CDS+ T cell subsets, as well as CD 19+ B cells were examined for 
h1L-4Ra expression. M I indicates surface expression of h1L-4Ra above that detected for the 
isotype and negative controls. Cells were pooled from 3 mice per group with results representing 
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hIL-4Ra Tg/ rnIL-4Ra .,. 
rnIgG 1 isotype control 
BALB/c 
rnIL-4Ra .,. 
Splenocytes and peritoneal exudate cells were isolated from na"ive BALB/c (black line), h1L-4Ra 
Tg/m1L-4Ra,I, (green line) and m1L-4Ra'I' (red line) mice and assessed for surface expression of 
hIL-4Ra. Cells from hIL-4Ra Tg/mIL-4Ra'I' mice were stained with the appropriate isotype 
control antibody (blue line). Non-lymphocyte populations were identified as MHC Ir F4/80+ and 
MHC It F4/80+ for macrophages, CD3' DXS+ for NK cells, MHC rr+CDllc+ for dendritic cells 
and GR-l+CDllb+ for granulocytes. Ml indicates surface expression of hIL-4Ra above that 
detected for the isotype and negative controls. Cells were pooled from 3 mice per group with 
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Results 
1.4 In vitro functional of chimeric IL-4R responsiveness 
1.4.1 Cell proliferation 
S T in vitro can by I 
I I on lymph 
a functional mouse thymidine 
during was used as a measure cell prol Is 








pro Ii feralion Is 
showed same but with lower 
confirm the 
or ml in vitro. 
1.4.2 T cell differentiation 
naIve T 
1990) while I 12 
and 
(Th) Is to 
el aI., I ). In order to 
T Is from h 
was in vitro. 
control as 
that h1L-4Ra in a 
mIL-4Ru'l-
When stimulated with ml 
were used as 
manner. Stimulation with ml 
Is 
stimu lation 






of IL-4R and 
Is in vilro et 




































































mlL ... 13 
-BALB/.:: 
... ,*. hlL-4Ra T gJ mlL-4Ra ./ . 
... .0-. mlL-4Ra ./. 
13 25 100 200 
m1L·13 (ng/ml) 
6. Cell proliferation oflymph node cells stimulated with mIL-2, mIL-4, hlL-4 or 
mlL-13. 
hlLARu 
In mice and stimulated with m1L ... 2 A), m1L ... 4 
or 11111, ... 13 (panel 0) in the presence of PMA (Sng/ml) 1ar 48 hrs. The 
the last 18 hI'S of culture was used as a measure of 
(n 4 mice per 
Cells from B/c and mlL-4Ro .... / ... were used as Purified 'T Is 
from narve cells were with bound 
of Ulml) with mI 
hi differentiation, or with 12 and anti ... i 
an additional 48 with 
IFN-y 





















. ll "r"lithr'l.ti"."  1
III l
Results 
mouse showed ability to 
lation with I L-12 and anti-I production in the right panel 
that C T Is from hIL-4Ra L-4Ra- l - had impaired 
with ml as did Is. In 
differentiation in h1L-4Ra but not in BALB/c and m 
had no visible on either IFN-y or I production in 




vitro Waal Malefyt et al 1996). In 
conclusion, hILA but not miLA induces differentiation T 
hi in vitro. 
_ BALBlc 
~ hll-4RaTg I mll4Ru-l- m1L-13 I anti-lFN" 
c::::I mll4R«-1-




m1L-12 I anti-lL4 
~dium 
7. In vitro Thl/T1l2 differentiation ofCD4+ T cells from BALB/c, hIL-4Ra 
and mice. 
CD4 T cells were from pooled lymph node cells of naIve hiL-
4Ra and mlL-4Rcr mice (11 3 mice per Cell were activated by plate-
in the presence of IL-2 and cultured with O1IL-12 anti-mIL-4 for 
or,forTh2 with and hILAormIL-13. 
72 hrs of cells were restimulated with anti-CD3 for 48 hrs and the levels of (left 
I of 3 panel) and IL-4 (right panel) in the by ELISA. The results r,>nr"",,>" 
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Macrophage .. ,,.,nr,,n to and rnl 3 
the production in iy activated 
1988; 1990a). This induction is 
mechanisms to alternative 
I activity (Doyle et aI., 1994; Corral 
Modolell et aI., et aI., 1996; 
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Figure 8. responsiveness to m1L-4 and mIL-l3. 
Pooled na"ive and mIL-4Rc(' mice 
5 per were stimulated medium alone or 16 hrs with medium, 
miLA or mIL-13 and stimulated with I After 48 hrs the NO 
(panel B) after the (panel 
was used as a measure of One experiment of 2 is shown 
with data mean 1: SEM of cultures. Statistical differences to the 
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Results 
In vivo disease studies 
2.1. Lei!<"hmania major infection 
2.1.1 major disease progression 
of LB/c to L. major infection is with a 
the production of 
show 
production of 
major is well 
receptor in hIL-4Ru Tg/mIL-4Ru-l -
e1 al 1989). In 
to L maior a shift 
to test the in vivo specificity 
19(9). 
eh 
this in vivo would allow 
the 
L 
of the I L-4-dependent in fection. 
Furthermore, the inducibility shed light on 
inl1uences 'Th2 or type 2 
BA hi the I control ml 111ICe 
were subcutaneously hind 
ulceration whi Ie 
m fU'II"t"I"lnt with no R(1,-I-
compared with a 
mice developed disease with 
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Results 
9. Footpnd lesion development L. major infection. 
4 mice per were 
Lesion development was 
between the in1ected and 
is shown with data mean 
The occurrence of ulceration and necrosis from individual mice is 
2.1.2 Increased parasites burden in h1L-4Ru Tg/mIL-4Ra·'-
To lity of L. in controll ing n"~''''''I'' 
bu rdens were in infected footpads and lymph nodes at 12 
cell were 
serially d 4 weeks 
In were 
similarly as well as in draining was 
with the comparable lesion for these two throughout 
mice were infection. 
compared 
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2.1.3 Type 2 antibody responses to major infection 
induces 
(Coffrnan el 1986; 
2 
and Paul, 1987). During L. 
Results 
and in mouse B cells 
type 2 antibodies which are reduced in that 
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11. responses in L. InI'lW'T-lll1tected mice. 
mice were with 2x I L. 
I, 
at O. week 4 and week 10 
determined ELISA. One 
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Figure 12. TotallgE production in response to L major infection. 
were collected at O. week 4 and week 10 
ELISA. One repreS,;nHltl 
shown. is expressed as mean SEM of 4 mice per group. 
to BAUVc values are indicated as '" 0.05 and ** 0.0 I. 
J.4 Cytokine response to major infection 
thy SA mice to L IS with the 
as I IL~ 13 and I 10 (I-:leinzel et aI., 1989, 1991; Reiner et 1994). 
test whether the susceptibi lity in hIL-4Rct is 
production of lymphocytes 
were were 
for 13 and 
IFN-y. Is increased amounts of I compared to 

























higher amounts of this cytokine (Fig. 13A). The h1L-4Ru Tg/mlL-4Ru-l - mice also 
expressed increased levels of IL-5 (Fig. 13B), similar to BALB/c mice, but significantly 
higher concentrations of lL-13 (Fig. 13C). In contrast, C57BLl6 and mIL-4Ru-l - mice 
made lower amounts of both IL-5 and IL-13 . The IFN-y production was elevated in 
C57BLl6 mice while being lower in BALB/c and hIL-4Ru Tg/mIL-4Ru-/- mice and even 
more reduced in mIL-4Ru-l - mice (Fig. 130). 
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Figure 13. Cytokine production in lymph node cells from L. major-infected mice. 
Single cell suspensions were prepared from pooled lymph nodes of week 4 L. major-infected 
mice (n = 4 mice per group) and restimulated with anti-CD3 for 72 hrs. The levels of IL-4, lL-5, 
IL-13 and IFN-y in cell supernatants were measured by ELISA. One representative of 3 
experiments is shown with the values representing mean ± SEM of triplicate cultures. Statistical 
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Results 
.5 Effect h1L-4 treatment on to L. major infection 
To whether hIL-4R/myc chimeric In 
ru as an inducible to L. 
major infection was in vivo treatment of 
1-\ 
4. 
been with 10jlg of I 
infection is iTTl"'''''''' to 
induce Th2 et 200 I; Sato et 1993: 
Himmelrich ct aI., were injected 10 in 
lone day before 2 post 
inlection. mice as were 
L. major LV39 left hind footpads 
swelling. previollsly nn",'r"p( 
et a!.. I Holscher ct ai., but 
were capable of 
hi 
had no lily mice to L. 
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14. }:tTect of h1L-4 treatment on lesion development L. major infection. 
Mice fh)m h1L-4Ru and strains were with 2xl L major in 
UVtlJ"~"" A group of h1L-4Ru Tg/mIL-4Ro:" mice was treated with h1L-4 on day - L 
The weekly and 
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Results 
2.].6 Type 2 antibody responses ill L. major-infected mice 
of hi treatment on non,,,,,,, in L 
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Figure 15. Effect of hIL-4 treatment on antibody responses in mice infected with L. major. 
Experimental mice were infected s.c. with 2x 106 L major and sera collected at day -I, week 7 
and week 12 post infection. Antigen-specific IgG I, IgG2a and JgG2b as well as total 19E titers 
were determined by ELISA. Data points represent mean ± SEM of 3 mice per group. For total 
IgE values, statistical analysis was performed using unpaired Student t test defining differences to 
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Nippostrongylus brasiliensis infection 
W orrn expulsion 
is IL-13 dependent and requires lL-4Ra 
et 1998, I; et aI., 
were shown to deficient in m1L-4Ra and it was 
mice would not 
brasiliensis 
their worm expulsion fecundity. As 
the 
time point (Fig. 16A). 
could wi while 
in hlL-4Ra and m I L-4 Rc(!' to an inability 
to brasiliensis worms 16B). 
mice do not IL-4Ra on non-bone marrow derived 
B 
liliiii BALBlc * 
ESSI I mIL""R,x'" 
Cl 
Day 7 Day 14 Days post infection 









BA hlLARu and mIL-4Ru' mice were infected s.c. with 750 L3 N. 
brasiliensis larvae. A. At day 7 and 14 infection the number worms in intestines of 
individual mice were determined. B. Worm egg production was determined 
mice and as eggs per gram feces. One of 
data mean SEM of 4 mice per group. 
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a infection (Fig. 
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17. Antibody responses in N. brasiliensis-infected mice. 
Scm mice~ 
total IgG 1. antibodies measured ELISA. One rf>rw,,,,·,,,,, 
shown and data is as mean SEM of 4 
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Neutralization of mIL-4 
Worm expulsion of N. 
The I by B lymphocytes in 
in vivo. 
ml was neutral anti-miLA antibodies during 
with 0.5 
is sufficient to 
man et 
Debus et aI., 2003). Thus. 
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were unable to 
and untreated hi 
worms while both BALB/c 
14 19A). A resu It was seen in the 
this 
treatment was unable to suppress production 
et Urban et 1998), 
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of BALB/c 
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Figure 19. Expulsion of N. brasiliensis after neutralization of mIL-4. 
BALB/c and hIL-4Ru TgimIL-4Ru-'- mice were injected intraperitoneal with anti-mIL-4 (+ anti-
IL-4) and infected subcutaneously with N brasiliensis one day later. Treated mice received a 
second dose of anti-mIL-4 at day 7 after infection. As control an untreated group of mIL-4Ru'/' 
was infected with N brasiliensis. A. The number of worms in intestines of individual mice was 
counted on day 7 and day 14 post infection. B. The fecal eggs were counted daily in samples from 
single mice with the values for day 14 shown. The results are representative of 2 independent 
experiments with values representing mean ± SEM of 4 mice per group. Statistical differences 
compared to BALB/c values are indicated as * p< 0.05 and *** p< 0.001. 
2.3.2 Antibody responses to N. brasiliensis after neutralization of mIL-4 
To determine the effects of IL-4 neutralization on antibody responses in hIL-4Ru 
Tg/mIL-4Ru'/' mice, total IgG 1, IgG2a, IgG2b and IgE production were analyzed . N. 
brasiliensis-infected mice were bled on day 14 post infection and their total serum 


























and anti-ml LA treatment had no on the 
of this antibody (Fig. 20A). was 
higher in mIL-4Ra-;· mice compared to Anti-mIL-
4 treatment no on serum levels 
in hI m ice so that it was 
in hi 
this 
mIL-4 had a more 
levels of IgE in both 
significantly decreased in animals treated 
in the ml L-4Ra-i -
experiments and clearly indicate that 
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in hlL-4Ra Tg/mIL-4R({/· 
Effcct of anti-mIL-4 treatment on cytokinc production 
The effect of m1L-4 
whether endogenous ml 
transgenic mice. Purified 
infected mice were 
were 
4Ra 
(Fig. 21). The 
corresponded to 
II and I 13 in 
slightly increased in 
the hi II 
cytokine responses in 
the chimeric 
on was analyzed, to determine 
observed in brasiliensis-infected 
lymph nodes of day 7 
levels of IL-4, IL-5, IL-13 
BALB/c and hfL-
while 
strains. I FN-y production was 
with anti-mIL-4 while being 111 
that ami-miLA treatment 






















BAI..8/c hlL-4Ra Tot hlL-4Ra Tot mlL-4Ra.,/· 
+ Mti-lL-4 mIL-4Ra -l· mlL-4Ra -l· 
+ .ntl-IL-4 
D 
hlL-4Ra Tot hlL-4Ra Tot mlL-4Ra -l-














hlL-4Ra Tot hlL-4Ra Tot nL-4Ra -l· 
+ .ntl-lL-4 mlL-4Ra.,/· rriL-4Ra-l-
+ .nti-IL-4 
NO 
hlL-4Ra Tot hlL-4Ra Tot mlL-4Ra-l-
+ MtI-IL-4 mlL-4Ra -I- mlL-4Ra-l-
+ .ntI-IL-4 
Figure 20. Antibody production in N. brasiliensis-infected mice treated with anti-mIL-4. 
BALB/c, hIL-4Ra Tg/mIL-4Ra-l - and mIL-4Ra-r mice were infected subcutaneously with 75013 
stage N brasiliensis larvae. Groups of BALB/c and hIL-4Ra Tg/mIL-4Ra- l - mice were treated 
with anti-mlL-4 one day prior to infection and at day 14 after infection (+ anti-IL-4). Sera 
samples were collected at day 14 post infection and the total IgG I, IgG2a, IgG2b and IgE 
antibodies measured by ELISA. The results are representative of 2 independent experiments with 
values representing the mean ± SEM of 4 mice per group. Unpaired Student f test was used to 
determine statistical differences compared to BALB/c mice or to untreated groups where 
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Figure 21. Cytokine production in anti-mIL-4 treated mice infected with N. brasiliensis 
BALB/c, hIL-4Ra Tg/mIL-4Ra-l - and mIL-4Ra-l - mice were infected subcutaneously with 750 L3 
stage N brasiliensis larvae. Groups of BALB/c and h1L-4Ra Tg/mIL-4Ra-f- mice were treated 
with anti-mIL-4 one day prior to infection and at day 14 after infection (+ anti-IL-4). CD4" T 
cells were purified from pooled mesenteric lymph nodes of day 7 infected mice (n = 4 mice per 
group) and restimulated with anti-CD3 for 72 hrs. The levels of IL-4, IL-5, IL- 13 and fFN-y in 
cell supernatants were measured by ELISA. The results are representative of 2 independent 
experiments with data representing mean ± SEM of triplicate cultures. Unpaired Student I test 
was used to determine statistical differences compared to untreated groups where indicated 
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Results 
3 III vivo of h1L-4Ra Tg/ mIL-4Ra-l- /mIL-4-1- ImIL- mice 
I Generation and analysis of hIL-4Ra Tg/mfL-4Ra-I-1 






neutral ization ml is 
approach, to confirm that IL-4 
receptor Both 
background for more than 10 
were by 
mIL-4RCt knockout allele 
Tg/mIL-4Ra was 
and 13 three primers were 
mouse while the ampl 
ampl both products are 
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Figure 22. Genotyping of hIL-4RaTg/mIL-4Ra-'-ImIL-4-
1
- ImIL-13-'- mice 
Four peR reactions were used to identity hIL-4Ru TgimIL-4Ru--/mIL-4-'-/mIL-13- mice_ 
A. peR reactions using primers to the 600bp wild-type allele, the 471 bp knockout allele and the 
hIL-4Ru transgene_ Lanes I and 2 contain peR products from transgenic mice for wild-type 
allele; lanes 3 and 4 contain peR products for knockout allele and lanes 5 and 6 contain peR 
products for h1L-4Ru transgene. A DNA marker was loaded in lane 8 and a negative control in 
lanes 7. B. peR reactions using primers to the mIL-4/IL-13 allele. Lanes I and 2 contain the peR 
products from IL-4/ IL-13-" mice, lane 3 contains DNA from a hlL-4RuTgimIL-4Ru-'- ImIL-4--
ImIL-13-1- mouse and lane 4 contains peR products from WT BALB/c mice. A DNA marker was 
loaded in lane 6 and a negative control in lane 5. The sizes (in bp) of the DNA marker are 
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Figure 23. Worm eXIPUlSIO,n of N. brasilien ... is in h1L-4Ra 
mice. 
BALS/c. hIL-4RfL 
individual mice were 
SEM of 4 mice per group. 
















Antibody to N. brtlsiliensis infection 
I, 
hi 
were measured in sera of 
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infection, cytokine production was 
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Figure 25. Cytokine production of C()4+ T cells from hi L-4Ru Tg/m IL-4Ru'/' ImIL-4'/ Iml L-
13'/' mice infected with N. brasiliensis ' 
CD4' T cells were purilied from pooled mesenteric lymph nodes of day 7 /II, hrasiliensis-infected 
mice (n 4 mice per group). Cells were restimulated with anti-CD3 for 72 hrs and the levels of 
lL-4 and !L-13 in cell supernatants measured by ELISA. Data represent mean ± SEM of triplicate 
cultures. Statistical differences between groups are indicated as * p< 0.05 and ** p< 0,01. 
3.3 Immune response to L. major infection 
3.3.1 Footpad lesion development after infection with L. major 
"1'0 determine whether the absence of m1L-4 and m1L-13 rendered hi L-4Ra Tg/ mIL-4Ra' 
/. mice resistant to L major infection, BALB/c, C57BLl6. h1L-4Ru Tg/mIL-4Ru'/', mlL-
4Ru· j · and h1L-4Ra Tg/mIL-4Rfl'/- ImIL-4'/' ImIL-1 mice were infected with 2xl06 L. 
major promastigotes in the hind footpads. Due to time constraints mice were infected 
with the more virulent L. major substrain MOHM/IL/81/FEBNI. BALB/c mice infected 
with this strain develop more rapid footpad swelling compared to mice infected with L. 
major LV 39, MRIIO/Sv/59/P (Biederman et a1., 2001). Disease progression was 
followed by weekly fc)otpad measurements. Surprisingly, hIL-4Ra Tg/ mIL-4Ra-/' ImIL·, 
ImIL-13- j , mice were as susceptible to L. major infection as h1L-4Ru Tg/mIL-4Ru'/' 
mice indicating that the presence of the hIL-4Rc£ transgene is sufficient to induce 
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Figure 26. Footpad lesion development in the absence ofIL-4 and lL-13 during L. m{~i(}r 
infection. 
SAUVc, C57BLl6. hlL-4Ra Tg/mfL-4 , mIL-4Rf.(' and hlIARn Tg/mIL-4Rn+ ImIL-4'!' ImIL-
1 mice were in1ected with 2xl0(' L major MOHM/ILl81/FEBNJ promastigotes in the hind 
fi)otpads. Lesion development was monitored weekly and footpad swelling calculated as the 
di !Terence between infected and unintccled fi.)Olpads. Data represents the mean footpad swell i ng 1 
SEM of 8 rnice per group. For each group 4 mice were killed at week 4 p.i. and the rest at week l) 
p.i. The occurrence of ulceration and necrosis from individual mice is indicated with an asterisk (*). 
3.3.2 Parasite burdens of transgenic mice in the absence of lL-4 and lL-13 
To determine whether the increased footpad swelling in IL-4/IL-13-deficient transgenic 
m correlated with an inability to control parasite growth, parasite burdens were 
determined in infected draining popliteal lymph nodes at week 4 and week 9 p.i. As 
observed previously, the parasite burdens in lymph nodes after 4 weeks of infection were 
similar in BALB/c. m1L-4Ra and both hi Ru transgenic strains (data not shown). 
Consistent with the lesion development, BALB/c lymph nodes contained high numbers of 
parasites at week 9 p.i., while C57BLl6 mice showed no parasites at this time point (Fig. 
27). The parasite burdens in the two h1L-4Ra transgenic strains were equally enhanced 
and were signiticantly higher than that observed for ml LARa-!- mice. As reported 
previously, mIL-4Ra- l - mice harbored more parasites in lymph nodes compared to 
C57BLl6 mice. These data confirm that transgenic mice, even in the absence or mILA 
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Figure 27. Parasite loads in lymph nodes of L. major-infected mice. 
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28. Antibody responses in hIL-4Ra 
with L major 
tmIL-1SI. mice infected 
C57BL/6. h1L-4Ru TgimIL-4Ru', mIL-4Rt{ and hlL-4Ru Tg/mIL-4Rc(' ImIL-4'!' / 
mice were infected with 2x 106 L. MOil M/ILl81 IFEBN I in the hind 
Sera samples were collected at day 0 and 8 and the levels of L. major-
I and IgG2a antibodies as well as total by ELISA. Data represents mean 

























Transgenic BALB/c mice expressing human IL-4Rfl under the control or an intronic 
enhanct~r element of the Ig H chain (I::Jl) locus promoter, were recently general(~d to study 
the temporal role of IL-4 signaling in Th2 differentiation in vitro (Seki et aI., 2004). The 
E~l element functions in Band T cells (Grosschedl et ai., 1984; Kemp et aI., 1980). and in 
transgenic mice, linkage of E~l to genes (such as chloramphenicol acetyl transferase or 
Thy-I) hus been shown to provide Band T cell-specific expression (Chen el ai., 1987; 
Reik et al., 1987). In the study by Seki e1 al (2004) the h1L-4Ra gene linked to Ell was 
introduced into the germtine or BDFI mice and backcrossed with BALB/c mice, 
resulting in lymphocyte-specific expression of hIL-4R!1 on a BALB/c background. In 
lymphocytes, hlLARct may interact with myc to form a functional chimeric type I IL-4R 
(Andrews et aL, 200 I). Furthermore, due to the species-specific binding of murine and 
human ILA to their respective receptors, the hlLARa/myc chimeric receptor may be 
responsive to h1L-4 but not miLA (Lowenthal et aI., 1988; Park et aI., 1987a; 1987b). 
The species-specificity and function of the hlLARu/myc chimeric receptor in h1L-4Ru 
Tg mice were confirmed by the hIL-4-induced proliferation of Band T cells from 
transgenic mice. On the other hand, cells from BALB/c mice could not proliferate in 
response to h1L-4 (Seki et al., 2004). In addition, h1L-4 stimulated the Th2 differentiation 
of CD4+ T from hIL-4Ro. Tg mice similarly to mIL-4-induced Th2 differentiation of 
CD4' T cells from BALB/c mice. [n order to eliminate signaling via mIL-4 in hi L-4R!1 
Tg mice and generate a fully h1L-4 inducible system, h1L-4Ru Tg mice were backcrossed 
to mIL-4Rc(! BALB/c mice. The resulting hlLARa Tg/ mlL-4Ro.·/ mice allowed for the 
Th2 differentiation of TCR activated CD4+ T cells only when stimulated with hILA. It 
was demonstrated that h1L-4 added to CD4 t T cells in the initial 48 hrs after TCR 
activation resulted in Th2 lineage commitment. Delaying hIL-4 treatment to later time 
points resulted in impaired Th2 differentiation, clearly showing temporal restrictions on 
ILA-induced CiATA3 expression, and induction of T112 differentiation in vitro. 
Comparable results were observed in cells from hi L-4Ru Tg/ rnl LARu /- mice and anti-
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and the presence of the h1L-4Ru transgene. Phenotypic analysis showed that hlL-4Ra 
Tg/mIL-4R(:(i mice did not express mouse IL-4Ra but did express hIL··4Ru in the 
lymphocyte populations, CD4T , CDS" T cells, and CD19' B cells. However, h1L-4Ra 
surface expression was not observed in all lymphocytes. About 62% of CDJ' CD4' T 
cells, 69% orCD3! CDS+ T cells and 37% of CD 19+ 13 cells expressed hIL-4RrL The non-
lymphocyte populations NK cells, granulocytes and macrophages showed no surtllce 
expression of hlL-4Rct but some hIL-4RcL expression was detected in 8% of dendritic 
cdls and 9% on--JK cells. In the study by Seki et al (2004), the investigators stated that 
the h1L-4Ra transgenic line selected expressed hIL-4R similarly to mIL-4R in Band T 
cells. However, it was not specified how expression was quantified and it is possible that 
their expression studies were done under different conditions. Furthermore, the study was 
restricted to lym phocyte populations and no mention was made about hI L-4Ra 
expression in non-lymphocyte populations. It is not surprising that h1L-4Ra is expressed 
differently to mlL-4Ra as the hi L-4Ra transgene is under the control of Ell and not the 
m1L-4Ru promoter. Most studies using Ell-linked transgenes show no detectable levels of 
the transgenes in non-lymphocyte populations (Momy et aI., 1990). Some low levels of 
transgene expression in mice with an E~l-controlled N-myc transgene were attributed to 
infiltrating lymphocytes in the organs studied (Dildrop et aI., 1(89). Another study 
showed that an E~l-linked transplantation antigen gene (H-2Kb) was not only expressed 
in 13 and T cells but also in a subset of splenic epithelium (Allison el ai., 1990). 
Our functional analysis confirmed the lymphocyte-specific expression and function of 
hIL-4Ra, as described before (Seki et aI., 2004) et al). Stimulation with hIL-4 resulted in 
prolileration of lymphocytes and Th2 di!Terentiation ol'murine CD4+ T cells while mOllse 
IL-4 had no effect. The lack of IL-13 signaling confirmed previous findings that mouse T 
and B cells do not respond to IL-13 (Zurawski ct al., 1993), and that h1L-4Rn can not 
form a functional type II IL-4R with mlL-URnl (Andrews et al., 2001). 
I L-4 and IL-13 arc able to suppress IFNy/LPS-induced NO production of BALB/c 
macrophages by an IL-4RCL-dependent mechanism (Doherty et aI., 1993; Doyle et a1., 
1994; Modolell et al., 1(95). Macrophages from IL-4Ra-l - mice show no suppression 01' 
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